This is Thomas Sullivan's Typepad Profile.
Join Typepad and start following Thomas Sullivan's activity
Join Now!
Already a member? Sign In
Thomas Sullivan
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
Infusion Association Asks For Kickback Safe Harbor For Expensive Biologics Drug manufacturers routinely offer copayment coupons to reduce or eliminate the cost of patients' out-of-pocket payment for certain drugs. This financial assistance can be especially beneficial for patients who require... Continue reading
Posted 2 days ago at Policy and Medicine
Image
Massachusetts last week introduced a bill that calls for more transparency in the prices drug manufacturers charge for certain “critical prescription drugs.” Like California and Oregon before it, Massachusetts S. 1048 would require that companies report a wide range of... Continue reading
Posted 3 days ago at Policy and Medicine
Image
On April 20, the U.S. Department of Health and Human Services Office of Inspector General (OIG) announced the release of a new a guidance document entitled, Practical Guidance for Health Care Governing Boards on Compliance Oversight. “This new educational resource... Continue reading
Posted 4 days ago at Policy and Medicine
Image
We have covered drug shortage issues numerous times, including their impact on the healthcare system and patient care. Previous government studies have concluded that its own regulatory agencies have failed to address the problem, and in some cases may be... Continue reading
Posted 4 days ago at Policy and Medicine
Image
The 2015 FDLI Annual Conference kicked off yesterday in Washington, DC. The conference hosted a variety of impressive speakers from the Food and Drug Administration, as well as FDA lawyers and in-house counsel. Dr. Stephen Ostroff, the Acting Commissioner at... Continue reading
Posted 5 days ago at Policy and Medicine
Image
On Thursday, April 16, President Obama signed into law the legislation ending and replacing the Sustainable Growth Rate (SGR) Formula, which would have reduced Medicare physician payments by 21 percent. Perhaps foreshadowing the dawn of a new age of physician... Continue reading
Posted 6 days ago at Policy and Medicine
Image
On Wednesday afternoon, the Centers for Medicare and Medicaid Services (CMS) held a teleconference for physicians and teaching hospitals to help them through the process of reviewing their Open Payments data and potentially disputing their information. Notably, CMS has streamlined... Continue reading
Posted Apr 17, 2015 at Policy and Medicine
Image
Newsweek writer Kurt Eichenwald last month wrote an op-ed entitled “The Ugly Civil War in American Medicine,” in which the author derided the American Board of Internal Medicine’s (ABIM) certification process for doctors. The author accused the ABIM of requiring... Continue reading
Posted Apr 17, 2015 at Policy and Medicine
Image
The Department of Justice has announced the official settlement with Health Diagnostics Laboratory Inc. (HDL), of Richmond, Virginia, as well as with Singulex Inc., of Alameda, California. The companies will pay a total of $48.5 million to resolve kickback related... Continue reading
Posted Apr 16, 2015 at Policy and Medicine
Image
Wednesday, April 15; 2-3:30 pm ET During this MLN Connects National Provider Call, the Centers for Medicare and Medicaid Services (CMS) will provide a brief overview of Open Payments and describe the ongoing review and dispute period, when physicians and... Continue reading
Posted Apr 15, 2015 at Policy and Medicine
Image
The U.S. healthcare system spent $373.9 billion on prescription drugs in 2014, up 13.1 percent from the year before, and the highest rate of spending growth since 2001, according to a report by IMS Institute for Healthcare Informatics. View the... Continue reading
Posted Apr 15, 2015 at Policy and Medicine
Image
In today's highly regulated healthcare environment, commercial compliance has become among the most pressing topics on the minds of pharmaceutical and medical device executives. Yet, there is no single publication that goes deep enough to shed light on the myriad... Continue reading
Posted Apr 15, 2015 at Policy and Medicine
Image
GlaxoSmithKline’s 2012 Corporate Integrity Agreement made mandatory the company’s “Patient First” program (or a “substantially equivalent” program), under which GSK agreed not to provide incentive compensation or discipline to its sales reps based upon the volume of sales of GSK... Continue reading
Posted Apr 14, 2015 at Policy and Medicine
Image
Thomas Stossel, American Cancer Society Professor of Medicine at Harvard Medical School and a visiting scholar at the American Enterprise Institute, recently wrote an article entitled “Myths that undermine medical research.” Stossel raises important points to counter three prevailing myths... Continue reading
Posted Apr 14, 2015 at Policy and Medicine
Image
The Food and Drug Administration last week finalized two guidances intended to speed the process of getting innovative medical devices to patients in need. The Agency discussed its guidances in an article entitled “Providing Timely Patient Access To High-Quality, Safe... Continue reading
Posted Apr 13, 2015 at Policy and Medicine
Image
A recent article published in Forbes argues that online medical education has the opportunity to revolutionize training for doctors and nurses in emerging markets. Internet-based learning tools “will increase the number of health workers globally and train them to provide... Continue reading
Posted Apr 10, 2015 at Policy and Medicine
Image
To comply with the Physician Payments Sunshine Act, drug and medical device manufacturers submitted their 2014 Open Payments reports to the Centers for Medicare and Medicaid Services (CMS) on Friday, April 3. On Monday, April 6, the dispute resolution process... Continue reading
Posted Apr 9, 2015 at Policy and Medicine
Image
This month we are launching our newest publication, Life Science Compliance Update. This publication promises to deliver in-depth analysis of important compliance issues for both pharmaceutical and device companies and those who serve that industry. Each issue covers important news... Continue reading
Posted Apr 8, 2015 at Policy and Medicine
Image
This month we are launching our newest publication, Life Science Compliance Update. This publication promises to deliver in-depth analysis of important compliance issues for both pharmaceutical and device companies and those who serve that industry. Each issue covers important news... Continue reading
Posted Apr 8, 2015 at Policy and Medicine
Image
The House Ways and Means Subcommittee on Oversight recently held a hearing on the federal government’s use of data analysis to confront Medicare Fraud. The hearing featured testimony from Dr. Shantanu Agrawal, Deputy Administrator and Director of the Center for... Continue reading
Posted Apr 8, 2015 at Policy and Medicine
Image
Last week we posted a comprehensive look at the increased scrutiny into laboratories that engage in referrals with physician practices. That article looked at the (forthcoming) multi-million dollar settlement between the Department of Justice and Health Diagnostic Laboratories to settle... Continue reading
Posted Apr 6, 2015 at Policy and Medicine
Image
Arnold & Porter is hosting a full-day, interactive program aimed at providing industry professionals with unique real world enforcement perspectives and best practices to prepare for and respond to FDA and European inspections and enforcement actions. The program will take... Continue reading
Posted Apr 6, 2015 at Policy and Medicine
Image
Consumer advocacy group Public Citizen is calling on the Food and Drug Administration (FDA) to “stop the apparently violative off-label promotional statements” in various Type 2 Diabetes advertisements, which the group argues are being advertised as weight-loss drugs. “[N]one of... Continue reading
Posted Apr 3, 2015 at Policy and Medicine
Image
Referral arrangements between laboratories and physicians have received a lot of scrutiny lately. Last week, it was reported that Health Diagnostic Laboratory Inc. is nearing a $50 million settlement with the Justice Department to settle an investigation into the lab’s... Continue reading
Posted Apr 2, 2015 at Policy and Medicine
Image
Learn new strategies to streamline Open Payments reporting and leverage data analytics to improve risk management and commercial strategy at this year's Transparency Reporting West conference, being held April 21-22 in San Diego, California. The conference offers an impressive array... Continue reading
Posted Apr 1, 2015 at Policy and Medicine